Projected Growth of the Global Biochips Market to Reach $25.78 Billion by 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the biochips market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Biochips Market By The End Of 2029?
The biochips market has experienced significant expansion recently. Its valuation is projected to increase from $12.62 billion in 2024 to $14.61 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 15.7%. Historically, this expansion has been driven by several factors, including a rise in the need for personalized medicine, the widespread occurrence of chronic illnesses, advancements in technology, broader uses in drug discovery, increased investment in research and development, and conducive regulatory environments.
The biochips market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $25.78 billion by 2029, achieving a compound annual growth rate (CAGR) of 15.2%. The expansion during the forecast duration is fueled by the increased adoption in point-of-care diagnostics, broader applications in drug development, a growing need for personalized medicine, continuous progress in microfluidics technology, escalating investments in research and development, strengthening collaborations between biotechnology firms and academic entities, and new avenues in agricultural biotechnology. Significant trends identified for the forecast period include further advancements in microfluidics technology, a concentrated effort on designing biochips for liquid biopsy uses, an increasing need for multiplexed assays to concurrently detect multiple analytes, the incorporation of artificial intelligence for data analysis, and the introduction of innovative biochip platforms.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp
Which Business Drivers Are Underpinning The Growth Of The Biochips Market?
The increasing adoption of personalized medicines is anticipated to fuel the expansion of the biochips market moving forward. Personalized medicine involves customizing medical care to individual characteristics, such as genetics or lifestyle, to enhance efficacy and minimize adverse reactions. The rising demand for personalized medicine is propelled by its capacity to deliver more effective treatments, progress in genomics, the growing complexity of diseases, and regulatory backing. Biochips support personalized medicine by enabling exact and tailored treatment plans designed for an individual’s genetic profile. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, which is an increase compared to six in 2022. Hence, the increasing embrace of personalized medicines is driving the growth of the biochips market.
What Are The Principal Segment Types In The Biochips Market?
The biochipsmarket covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
2) By Technology: Microarrays, Microfluidics
3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
Subsegments:
1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays
2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays
3) By Lab-On-Chip: Microfluidic Devices, Biosensors
4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays
5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays
How Are Industry Trends Steering The Expansion Of The Biochips Market?
Major companies in the biochips market are directing their efforts toward developing advanced technologies such as organ-on-a-chip platforms, aiming to transform drug discovery and development processes. These organ-on-a-chip platforms are sophisticated microfluidic devices created to replicate the physiological characteristics and functions of human organs in a scaled-down format. For instance, in April 2024, Boston Micro Fabrication (BMF), a US-based nanotechnology research company, introduced BMF Biotechnology Inc. BMF Biotechnology Inc. specializes in Biochips, also known as organ-on-a-chip platforms, which are designed to cultivate large-scale tissues in vitro. This innovation provides a platform for testing and research outside the human body, thereby facilitating the accelerated development of new drugs and cosmetics.
Which Companies Are Contributing Significantly To The Biochips Market Growth?
Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/biochips-global-market-report
Which Region Offers The Most Opportunity For Biochips Market Expansion?
North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp
Browse Through More Reports Similar to the Global Biochips Market 2025, By The Business Research Company
Oral Biologics And Biosimilars Market 2025
https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market
Biosimilar Growth Hormone Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Microbiomes Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
